Yan Ling Li

Corporate Officer/Principal bei Jiangsu Vanguard Pharmaceutical Co., Ltd.

60 Jahre

Health Technology

Consumer Services

Aktive Positionen von Yan Ling Li

Unternehmen	Position	Beginn	Ende
Jiangsu Vanguard Pharmaceutical Co., Ltd. Jiangsu Vanguard Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Vanguard Pharmaceutical Co., Ltd. engages in the research, development, production and sale of chemical drugs and proprietary Chinese medicines. Its products include valsartan hydrochlorothiazide tablets, calcium dobesilate capsules, calcium carbonate D3 chewable tablets, irbesartan hydrochlorothiazide tablets, bezafibrate dispersible tablets, aluminum magnesium carbonate chewable tablets, amlodipine maleate dispersible tablets, brucei seed oil soft capsules. The company was founded by Guang Xue He on November 28, 2003 and is headquartered in Nantong, China.	Corporate Officer/Principal	01.12.2019	-

Shenyang Pharmaceutical University

Undergraduate Degree

International

China

Operativ

Corporate Officer/Principal	1
Undergraduate Degree	1

Sektoral

Health Technology	2
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	1
Jiangsu Vanguard Pharmaceutical Co., Ltd. Jiangsu Vanguard Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Vanguard Pharmaceutical Co., Ltd. engages in the research, development, production and sale of chemical drugs and proprietary Chinese medicines. Its products include valsartan hydrochlorothiazide tablets, calcium dobesilate capsules, calcium carbonate D3 chewable tablets, irbesartan hydrochlorothiazide tablets, bezafibrate dispersible tablets, aluminum magnesium carbonate chewable tablets, amlodipine maleate dispersible tablets, brucei seed oil soft capsules. The company was founded by Guang Xue He on November 28, 2003 and is headquartered in Nantong, China.	Health Technology

Private Unternehmen

Health Technology